Table 3.
Distribution of antibiotic classes used among inpatients at baseline and project endpoint in the University Hospital, KNUST.
| Antibiotic classes prescribed | Baseline (%) | Midpoint (%) | Endpoint (%) |
|---|---|---|---|
| Penicillin with extended spectrum (Piperacillin/tazobactam) | 4.8 | 0 | 3.8 |
| Penicillin with beta-lactamase inhibitors (Amoxicillin/clavulanic acid) | 11.9 | 21.4 | 17.3 |
| Second-generation cephalosporins (cefuroxime) | 11.9 | 9.5 | 13.5 |
| Third-generation cephalosporins (ceftriaxone, cefixime) | 21.4 | 14.3 | 21.2 |
| Carbapenems (meropenem) | 2.4 | 0 | 1.9 |
| Macrolides (azithromycin) | 11.9 | 7.1 | 3.8 |
| Lincosamides (clinidamycin) | 11.9 | 9.5 | 9.6 |
| Fluoroquinolones (ciprofloxacin, levofloxacin) | 11.9 | 7.1 | 9.6 |
| Imidazole derivatives (metronidazole, tinidazole) | 11.9 | 14.3 | 9.6 |
| Aminoglycoside (gentamicin, amikacin) | 0 | 7.1 | 7.7 |
| Sulfonamide/trimethoprim | 0 | 4.8 | 0 |
| Tetracyclines (doxycycline) | 0 | 2.4 | 0 |